Topic

Aetna (CVS Health)

A collection of 1078 issues

Aetna (CVS Health) Coverage Criteria for Ultomiris (ravulizumab) in New York: What Counts as "Medically Necessary"?

Answer Box: Getting Ultomiris Covered by Aetna (CVS Health) in New York Ultomiris (ravulizumab) requires prior authorization from Aetna (CVS Health) for all FDA-approved indications (PNH, aHUS, anti-AChR+ generalized myasthenia gravis, and NMOSD). Coverage requires meeting diagnosis-specific criteria, meningococcal vaccination, and documentation of clinical necessity. Quick start: 1) Verify your
5 min read

Do You Qualify for Naglazyme (Galsulfase) Coverage by Aetna (CVS Health) in Georgia? Decision Tree & Next Steps

Quick Answer: Your Path to Naglazyme Coverage in Georgia You likely qualify for Naglazyme (galsulfase) coverage through Aetna (CVS Health) if you have confirmed MPS VI diagnosis via enzyme assay or genetic testing, plus documented functional limitations. Aetna requires prior authorization with specialist documentation and baseline assessments (6-minute walk test,
6 min read

Aetna (CVS Health)'s Coverage Criteria for Revlimid (Lenalidomide) in Virginia: What Counts as "Medically Necessary"?

Answer Box: Getting Revlimid (Lenalidomide) Covered by Aetna (CVS Health) in Virginia Aetna (CVS Health) covers Revlimid (lenalidomide) with prior authorization when medically necessary for FDA-approved indications like multiple myeloma and certain lymphomas. To qualify: (1) Submit PA with diagnosis confirmation, prior therapy history, and REMS enrollment proof; (2) Include
5 min read